Application 206760
- Type
- ANDA
- Sponsor
- PIRAMAL CRITICAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | OXACILLIN SODIUM | OXACILLIN SODIUM | INJECTABLE;INJECTION | EQ 10GM BASE/VIAL | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66794-227 | Oxacillin | Oxacillin | Piramal Critical Care Inc | ANDA | Current |
| 66794-227 | Oxacillin | Oxacillin | Piramal Critical Care Inc | ANDA | Current |
| 66794-227 | Oxacillin | Oxacillin | Piramal Critical Care Inc | ANDA | Current |
| 66794-227 | Oxacillin | Oxacillin | Piramal Critical Care Inc | ANDA | Current |
| 66794-227 | Oxacillin | Oxacillin | Piramal Critical Care Inc | ANDA | Current |
| 70655-103 | Oxacillin | Oxacillin Sodium | Renaissance SSA, LLC | ANDA | Current |
| 70655-103 | Oxacillin | Oxacillin Sodium | Renaissance SSA, LLC | ANDA | Current |